🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

Astellas Pharma Europe B.V. — Licensed Medicines

13 medicines held by Astellas Pharma Europe B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 13 products held by Astellas Pharma Europe B.V.
MedicineActive substanceLicence holderStatus
Betmiga 8 mg/ml Granules for prolonged-release oral suspension
EU/1/12/809/019-020
Mirabegron Astellas Pharma Europe B.V.
Evrenzo 100 mg Film-coated tablet
EU/1/21/1574/004
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 150 mg Film-coated tablet
EU/1/21/1574/005
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 20 mg Film-coated tablet
EU/1/21/1574/001
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 50 mg Film-coated tablet
EU/1/21/1574/002
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 70 mg Film-coated tablet
EU/1/21/1574/003
Roxadustat Astellas Pharma Europe B.V.
Padcev 20 mg Powder for concentrate for solution for infusion
EU/1/21/1615/001
Enfortumab Vedotin Astellas Pharma Europe B.V.
Padcev 30 mg Powder for concentrate for solution for infusion
EU/1/21/1615/002
Enfortumab Vedotin Astellas Pharma Europe B.V.
Veoza 45 mg film-coated tablets
EU/1/23/1771/001-003
Fezolinetant Astellas Pharma Europe B.V.
Vyloy 100 mg powder for concentrate for solution for infusion.
EU/1/24/1856/001-002
Zolbetuximab Astellas Pharma Europe B.V.
Xospata 40 mg film-coated tablets
EU/1/19/1399/001
Gilteritinib fumarate Astellas Pharma Europe B.V.
Xtandi 40 mg film-coated tablets
EU/1/13/846/002
Enzalutamide Astellas Pharma Europe B.V.
Xtandi 80 mg film-coated tablets
EU/1/13/846/003
Enzalutamide Astellas Pharma Europe B.V.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.